Bank Of Montreal Sangamo Therapeutics, Inc Transaction History

Bank Of Montreal

$214 Billion
Q3 2024

A detailed history of Bank Of Montreal transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Bank Of Montreal holds 12,057 shares of SGMO stock, worth $30,142. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,057

Holding current value

$30,142

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$0.32 - $1.1 $3,858 - $13,262	12,057 New	12,057 $10,000
Q2 2023 Aug 02, 2023	SELL	$1.11 - $1.74 $4,000 - $6,270	-3,604 Reduced 24.82%	10,919 $14,000
Q1 2023 Jun 13, 2024	BUY	$1.66 - $3.67 $27,429 - $60,643	16,524 New	16,524 $29,000
Q4 2022 Feb 01, 2023	BUY	$2.77 - $5.07 $6,567 - $12,020	2,371 Added 19.51%	14,523 $45,000
Q3 2022 Nov 10, 2022	BUY	$4.27 - $6.39 $2,869 - $4,294	672 Added 5.85%	12,152 $64,000
Q2 2022 Aug 11, 2022	BUY	$3.28 - $6.21 $2,610 - $4,943	796 Added 7.45%	11,480 $46,000
Q1 2022 May 12, 2022	SELL	$5.23 - $7.82 $10,460 - $15,640	-2,000 Reduced 15.77%	10,684 $63,000
Q4 2021 Feb 11, 2022	SELL	$7.29 - $10.97 $1.21 Million - $1.82 Million	-165,669 Reduced 92.89%	12,684 $99,000
Q3 2021 Nov 12, 2021	SELL	$9.01 - $12.01 $990,685 - $1.32 Million	-109,954 Reduced 38.14%	178,353 $1.7 Million
Q2 2021 Aug 12, 2021	BUY	$10.17 - $12.64 $2.93 Million - $3.64 Million	288,307 New	288,307 $3.38 Million

Others Institutions Holding SGMO

# of Institutions

115

Shares Held

56.4M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$48.6 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$24 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$12.1 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$11.8 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$5.88 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $391M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account